Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2008Clinical Cancer ResearchOpen Access

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

View Full Paper
Ask AI
Bookmark
Share

Authors

TLThehang LuuUniversity of Southern CaliforniaRMRobert J. MorganMayo ClinicLLLucille LeongCity Of Hope National Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Luu et al. (2008) studied this question.

synapsesocial.com/papers/6a80b90103a7c7d587cb0935https://doi.org/10.1158/1078-0432.ccr-08-0122
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas <i>In situ</i> and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis2006 · 241 citations
  2. 2Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-22005 · 186 citations
  3. 3We Should Desist Using RECIST, at Least in GIST2007 · 554 citations
  4. 4Histone Deacetylase Inhibitors: From Chromatin Remodeling to Experimental Cancer Therapeutics2003 · 82 citations